Literature DB >> 12034130

The neurocircuitry and receptor subtypes mediating anxiolytic-like effects of neuropeptide Y.

Ants Kask1, Jaanus Harro, Stephan von Hörsten, John P Redrobe, Yvan Dumont, Rémi Quirion.   

Abstract

This review aims to give a brief overview of NPY receptor distribution and physiology in the brain and summarizes series of studies, test by test and region by region, aimed at identification receptor subtypes and neuronal circuitry mediating anxiolytic-like effects of NPY. We conclude that from four known NPY receptor subtypes in the rat (Y(1), Y(2), Y(4), Y(5)), only the NPY Y(1) receptor can be linked to anxiety-regulation with certainty in the forebrain, and that NPY Y(2) receptor may have a role in the pons. Microinjection studies with NPY and NPY receptor antagonists support the hypothesis that the amygdala, the dorsal periaqueductal gray matter, dorsocaudal lateral septum and locus coeruleus form a neuroanatomical substrate that mediates anxiolytic-like effects of NPY. The release of NPY in these areas is likely phasic, as NPY receptor antagonists are silent on their own. However, constant NPY-ergic tone seems to exist in the dorsal periaqueductal gray, the only brain region where NPY Y(1) receptor antagonists had anxiogenic-like effects. We conclude that endogenous NPY has an important role in reducing anxiety and serves as a physiological stabilizer of neural activity in circuits involved in the regulation of arousal and anxiety.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12034130     DOI: 10.1016/s0149-7634(01)00066-5

Source DB:  PubMed          Journal:  Neurosci Biobehav Rev        ISSN: 0149-7634            Impact factor:   8.989


  81 in total

Review 1.  Tobacco addiction and the dysregulation of brain stress systems.

Authors:  Adrie W Bruijnzeel
Journal:  Neurosci Biobehav Rev       Date:  2012-03-03       Impact factor: 8.989

2.  BODIPY-conjugated neuropeptide Y ligands: new fluorescent tools to tag Y1, Y2, Y4 and Y5 receptor subtypes.

Authors:  Yvan Dumont; Pierrette Gaudreau; Manuela Mazzuferi; Daniel Langlois; Jean-Guy Chabot; Alain Fournier; Michele Simonato; Rémi Quirion
Journal:  Br J Pharmacol       Date:  2005-12       Impact factor: 8.739

3.  Effects of a selective Y2R antagonist, JNJ-31020028, on nicotine abstinence-related social anxiety-like behavior, neuropeptide Y and corticotropin releasing factor mRNA levels in the novelty-seeking phenotype.

Authors:  Cigdem Aydin; Ozge Oztan; Ceylan Isgor
Journal:  Behav Brain Res       Date:  2011-04-08       Impact factor: 3.332

Review 4.  30 years of dynorphins--new insights on their functions in neuropsychiatric diseases.

Authors:  Christoph Schwarzer
Journal:  Pharmacol Ther       Date:  2009-05-28       Impact factor: 12.310

5.  NPY Induces Stress Resilience via Downregulation of Ih in Principal Neurons of Rat Basolateral Amygdala.

Authors:  Heika Silveira Villarroel; Maria Bompolaki; James P Mackay; Ana Pamela Miranda Tapia; Sheldon D Michaelson; Randy J Leitermann; Robert A Marr; Janice H Urban; William F Colmers
Journal:  J Neurosci       Date:  2018-04-12       Impact factor: 6.167

Review 6.  Role of CRF and other neuropeptides in stress-induced reinstatement of drug seeking.

Authors:  Uri Shalev; Suzanne Erb; Yavin Shaham
Journal:  Brain Res       Date:  2009-07-23       Impact factor: 3.252

7.  Fear-reducing effects of intra-amygdala neuropeptide Y infusion in animal models of conditioned fear: an NPY Y1 receptor independent effect.

Authors:  Markus Fendt; Hugo Bürki; Stefan Imobersteg; Kurt Lingenhöhl; Kevin H McAllister; David Orain; Doncho P Uzunov; Frederique Chaperon
Journal:  Psychopharmacology (Berl)       Date:  2009-07-17       Impact factor: 4.530

8.  Npy deletion in an alcohol non-preferring rat model elicits differential effects on alcohol consumption and body weight.

Authors:  Bin Qiu; Richard L Bell; Yong Cao; Lingling Zhang; Robert B Stewart; Tamara Graves; Lawrence Lumeng; Weidong Yong; Tiebing Liang
Journal:  J Genet Genomics       Date:  2016-04-29       Impact factor: 4.275

9.  Y1 receptors regulate aggressive behavior by modulating serotonin pathways.

Authors:  Tim Karl; Shu Lin; Christoph Schwarzer; Amanda Sainsbury; Michelle Couzens; Walter Wittmann; Dana Boey; Stephan von Hörsten; Herbert Herzog
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-16       Impact factor: 11.205

10.  Evidence from knockout mice that neuropeptide-Y Y2 and Y4 receptor signalling prevents long-term depression-like behaviour caused by immune challenge.

Authors:  Evelin Painsipp; Herbert Herzog; Peter Holzer
Journal:  J Psychopharmacol       Date:  2009-11-25       Impact factor: 4.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.